Valens Semiconductor Ltd.·4

May 11, 9:06 AM ET

Chairman David 4

4 · Valens Semiconductor Ltd. · Filed May 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Valens Semiconductor (VLN) SVP David Exercises Options, Sells 4,000 Shares

What Happened

  • David, SVP R&D at Valens Semiconductor, exercised stock options and sold the resulting shares on May 8, 2026. The filing shows he acquired 4,000 shares by exercising options at $0.86 per share (cost $3,440) and then sold 4,000 shares in an open-market sale at a weighted-average price of $2.54 per share (proceeds $10,172). A related derivative entry was reported at $0.00, reflecting the option disposition on exercise. Net proceeds before taxes and fees were roughly $6,732.

Key Details

  • Transaction date: May 8, 2026; Form 4 filed May 11, 2026.
  • Exercise: 4,000 shares, $0.86 per share, total $3,440 (code M = exercise/conversion of derivative).
  • Sale: 4,000 shares, $2.54 weighted-average price, total $10,172 (code S = sale).
  • Footnotes: sale was executed under a Rule 10b5-1 trading plan adopted Aug 16, 2024 (F1); shares sold were acquired upon exercise of options the same date (F2/F4/F5); reported sale price is a weighted average (F3).
  • Shares owned after the transactions: not reported in the excerpt of the filing.

Context

  • This was effectively a same-day exercise-and-sell (cashless-style) transaction: options were exercised to acquire shares and those shares were sold that same day. The presence of a 10b5-1 plan indicates the sale followed a pre-established trading schedule rather than an ad-hoc decision. The filing provides factual transaction details but does not indicate insider intent.

Insider Transaction Report

Form 4
Period: 2026-05-08
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F1][F5]
    2026-05-08$0.86/sh+4,000$3,440407,968 total
  • Sale

    Ordinary Shares

    [F1][F2][F3]
    2026-05-08$2.54/sh4,000$10,172403,968 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-05-084,00083,695 total
    Exercise: $0.86From: 2022-06-01Exp: 2031-06-09Ordinary Shares (4,000 underlying)
Footnotes (5)
  • [F1]The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
  • [F2]The shares sold were acquired upon the exercise of stock options on the same date
  • [F3]The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
  • [F4]The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
  • [F5]The shares were acquired upon the exercise of stock options
Signature
David Chairman by: Oppenheimer Israel, as Attorney-in-fact|2026-05-11

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT